FDA approves Eylea for DME
[ad_1]
Another therapy has been approved for diabetic macular edema, one of the leading causes of vision loss in the United States….
Regeneron Pharmaceuticals, Inc. announced that the U.S. FDA has approved Eylea (aflibercept) for DME.
[ad_2]
Return to main website.